Cargando...

Palonosetron versus older 5-HT(3) receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis

BACKGROUND: No clinical standard currently exists for the optimal management of nausea induced by emetogenic chemotherapy, particularly delayed nausea. OBJECTIVE: To compare the efficacy and safety of palonosetron with older 5-HT(3) receptor antagonists (RAs) in preventing chemotherapy-induced nause...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Community Support Oncol
Autores principales: Morrow, Gary R, Schwartzberg, Lee, Barbour, Sally Y, Ballinari, Gianluca, Thorn, Michael D, Cox, David
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4734136/
https://ncbi.nlm.nih.gov/pubmed/25830233
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!